LongevityMap variant

Entry Details

Longevity Association: Non-significant
Population: English (Cambridge)
Study Design: Common polymorphism was examined in 182 women and 100 men aged > 84 years and in 100 boys and 100 girls younger than 17 years
Conclusions: Difference between genotypes in the elderly women and the young sample was observed. However, this did not retain significance when the genotype frequencies of the young sample were adjusted to values expected from the allele frequencies on the basis of Hardy-Weinberg equilibrium and compared to observed genotypes in elderly men and women.

Identifier: E2/E3/E4
In Other Studies (IDs): 5 8 9 11 51 55 68 86 99 131 171 190 224 229 373 374 3476
Cytogenetic Location: 19q13.32
UCSC Genome Browser: View 19q13.32 on the UCSC genome browser

HGNC symbol: APOE
Aliases: AD2; LPG; APO-E; ApoE4; LDLCQ5
Common name: apolipoprotein E
Description: The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016]
Other longevity studies of this gene: 30
OMIM: 107741
Ensembl: ENSG00000130203
UniProt/Swiss-Prot: A0A0S2Z3D5_HUMAN
Entrez Gene: 348
UniGene: 654439
HapMap: View on HapMap

GenAge model organism genes

GenAge human genes

GenAge microarray genes

Galinsky et al. (1997)